| Date Filed | Type | Description |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 08/04/2023 |
4
| SHEEDY CHARLES E (10% Owner) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Bought 62,500 shares
@ $2, valued at
$125k
|
|
| 08/03/2023 |
4
| CLAUSEN PETER (CSO/COO) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 25,000 shares
@ $2, valued at
$50k
|
|
| 08/03/2023 |
4
| Pittman Scott M. (10% Owner) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 100,000 shares
@ $2, valued at
$200k
|
|
| 08/03/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ... |
| 05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 03/31/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 12/05/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/04/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/04/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 10/20/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 10/20/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 10/18/2022 |
3/A
| CLAUSEN PETER (CSO/COO) has filed a Form 3/A on Nuo Therapeutics, Inc. |
| 09/30/2022 |
8-K
| Shareholder Nominations Pursuant to Exchange Act Rule 14a-11, Other Events Interactive Data |
| 08/30/2022 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits Inte... |
| 08/10/2022 |
10-Q/A
| Quarterly Report for the period ended June 30, 2022 [amend] |
| 08/08/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/05/2022 |
SC 13D/A
| SHEEDY CHARLES E reports a 39% stake in NUO THERAPEUTICS, INC. |
| 07/05/2022 |
SC 13D/A
| Pittman Scott M. reports a 18.6% stake in NUO THERAPEUTICS, INC. |
| 07/05/2022 |
SC 13D
| JORDEN DAVID EMERSON reports a 8.9% stake in NUO THERAPEUTICS, INC. |
| 06/28/2022 |
8-K
| Quarterly results |
| 06/15/2022 |
4
| CLAUSEN PETER (CSO/COO) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 275,000 options to buy
@ $0.75, valued at
$206.3k
|
|
| 05/19/2022 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 05/16/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 05/06/2022 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 05/02/2022 |
4
| JORDEN DAVID EMERSON (CEO/CFO) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 10,532 shares
@ $1, valued at
$10.5k
|
|
| 05/02/2022 |
4
| CLAUSEN PETER (CSO/COO) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 25,000 shares
@ $1, valued at
$25k
|
|
| 05/02/2022 |
4
| Pittman Scott M. (10% Owner) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 100,000 shares
@ $1, valued at
$100k
|
|
| 05/02/2022 |
4
| SHEEDY CHARLES E (10% Owner) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Bought 804,868 shares
@ $1, valued at
$804.9k
|
|
| 05/02/2022 |
8-K
| Quarterly results |
| 04/27/2022 |
DEF 14C
| Form DEF 14C - Other definitive information statements: |
| 04/26/2022 |
3
| CLAUSEN PETER (CSO/COO) has filed a Form 3 on Nuo Therapeutics, Inc. |
|